Press release
Neoantigen Targeted Therapies Market Size, Outlook And Industry Analysis Report 2024 To 2033
Neoantigen Targeted Therapies Market
Market Size And Growth Forecast:
The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from $2.43 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 39.3%. The growth in the historic period can be attributed to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, clinical success of checkpoint inhibitors, molecular profiling advancements.
The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $11.69 billion in 2028 at a compound annual growth rate (CAGR) of 36.3%. The growth in the forecast period can be attributed to advancements in bioinformatics, precision medicine expansion, neoantigen vaccine development, therapeutic combination strategies, biomarker validation. Major trends in the forecast period include neoantigen resistance management, neoantigen-primed adoptive cell therapies, neoantigen-based combinatorial therapies, integration of real-world data, enhanced predictive models.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
Market Segmentation:
The neoantigen targeted therapies market covered in this report is segmented -
1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, and Clinic, Other Applications
Major Driver - Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therapies Market
The increasing incidence of cancer cases is expected to propel the growth of the neoantigen targeted therapies market going forward. The incidence of cancer refers to the number of new cases of cancer in a specific population for a given period. Neoantigen targeted therapies are often used in combination to treat different types of cancer. For instance, the American Cancer Society (ACS), a US-based voluntary health organization, in 2022, the United States had 1.9 million new cancer cases, representing a significant increase compared to previous years. Furthermore, in 2022, in the US, approximately 609,360 deaths were attributed to cancer, emphasizing the profound severity and impact of this disease on individuals and their families. Therefore, the increasing incidence of cancer cases is driving the growth of the neoantigen targeted therapies market.
Competitive Landscape:
Major companies operating in the neoantigen targeted therapies market report are F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
Top Trend - Biontech Takes Strides In Neoantigen Targeted Therapies With The Launch Of Bnt122 For Colorectal Cancer
Product innovation has emerged as a key trend gaining popularity in the neoantigen targeted therapies market. Major players are focusing on creating innovative products to lead the market. For instance, in October 2021, BioNTech, a Germany-based biotechnology company, expanded its clinical oncology portfolio with the initiation of a Phase 2 clinical trial for 'BNT122', a mRNA-based individualized immunotherapy. This trial specifically focuses on colorectal cancer patients. The trial marks an important milestone, as the first patient has been dosed with BNT122. It is designed to harness the power of the immune system by stimulating a targeted T-cell response against neoantigens found in each patient's tumor. The ongoing clinical trial represents an important step forward in BioNTech's mission to develop cutting-edge immunotherapies and expand the treatment options available to cancer patients.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Neoantigen Targeted Therapies Market Characteristics
3. Neoantigen Targeted Therapies Market Trends And Strategies
4. Neoantigen Targeted Therapies Market - Macro Economic Scenario
5. Neoantigen Targeted Therapies Market Size And Growth
…..
27. Neoantigen Targeted Therapies Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Targeted Therapies Market Size, Outlook And Industry Analysis Report 2024 To 2033 here
News-ID: 3428554 • Views: …
More Releases from The Business Research Company
Smart Food Logistics Market Overview, Key Trends, and Insights on Top Players
The smart food logistics industry is rapidly evolving, driven by innovations aimed at enhancing the efficiency and safety of food transportation and storage. As technology becomes more integrated into supply chains, this market is poised for significant expansion in the coming years. Let's explore the projected market size, key players, emerging trends, and segment breakdowns shaping this dynamic sector.
Projected Market Size of the Smart Food Logistics Market by 2029
The smart…
Leading Companies Reinforcing Their Presence in the Silica Mineral Supplements M …
The silica mineral supplements market is gaining notable traction as consumers increasingly prioritize health and wellness. With rising interest in preventive care and new technological advancements, this sector is set for significant expansion. Let's explore the market's size, key drivers, leading companies, emerging trends, and the main segments shaping its future.
Market Size and Growth Outlook for the Silica Mineral Supplements Market
The silica mineral supplements market is projected to experience robust…
Global Trends Overview: The Fast-Paced Evolution of the Seed Protein Supplements …
The seed protein supplements market is gaining significant traction as consumers increasingly seek plant-based nutrition options. With evolving dietary preferences and technological advancements, this sector is poised for remarkable growth through the end of the decade. Below, we explore the market's size, key players, driving factors, trends, and segmentation to understand its future potential.
Projected Expansion of the Seed Protein Supplements Market Size Through 2029
The seed protein supplements market is set…
Market Structure, Emerging Trends, and Key Player Analysis in the Robotic Weldin …
The robotic welding fume extraction system market is rapidly evolving as industries prioritize safer and cleaner working environments. With the increasing use of robotic welding technologies and a focus on sustainable manufacturing, this sector is poised for significant growth. The following overview highlights the market's value projections, key players, prevailing trends, and segmentation details shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Robotic Welding Fume Extraction System…
More Releases for Neoantigen
Neoantigen Targeted Therapies Market Trends, Innovations, and Forecast Analysis
Neoantigen targeted therapies are a revolutionary class of immunotherapies that aim to stimulate the body's immune system to recognize and attack cancer cells. Neoantigens are tumor-specific antigens that arise from mutations in the DNA of cancer cells. These mutations produce abnormal proteins that are not present in normal cells, making them ideal targets for immune system recognition. Neoantigen-based therapies focus on developing personalized treatments by targeting these unique antigens, making…
Neoantigen Cancer Vaccine Market Size, Share & CAGR 69.43% to 2034
What is driving the explosive growth of the neoantigen cancer vaccine market?
The neoantigen cancer vaccine market is seeing one of the most rapid growth trajectories in modern oncology. With a market size of USD 116.74 million in 2024, it is projected to reach USD 22,757.41 million by 2034, growing at a CAGR of 69.43%. This unprecedented growth is being fueled by advancements in genomic technologies, the success of mRNA platforms…
Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Neoantigen Targeted Therapies Industry Market Size Be by 2025?
There has been a notable expansion in the market size of neoantigen targeted therapies in the last few years. This market is projected to grow from $3.4 billion in 2024 to $4.72 billion in 2025, experiencing a…
Neoantigen Peptides Manufacturing Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
The Neoantigen Peptides Manufacturing Market is expected to grow at a 16.0 % CAGR during the forecast period for 2023-2031.
Request for Free Sample…
Neoantigen Peptide Manufacturing Market Research Report 2023 - InsightAce Analyt …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4% during…
Latest Comprehensive Neoantigen Cancer Vaccine Market CAGR of 76% during forecas …
Neoantigen Cancer Vaccine Market Information:
Straits Research has recently added a new report to its vast depository titled Neoantigen Cancer Vaccine Market. The report studies vital factors about the Neoantigen Cancer Vaccine Market that are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share, profitability, production, sales, manufacturing, advertising, technological advancements, key market players, regional segmentation, and many…
